Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BNGO NASDAQ:DAIO NASDAQ:MSAI NASDAQ:PRPO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNGOBionano Genomics$1.68-4.5%$3.30$1.50▼$30.52$8.37M2.251.27 million shs1.04 million shsDAIOData I/O$3.25-0.3%$3.24$1.88▼$3.57$30.60M1.0435,799 shs7,812 shsMSAIMultiSensor AI$0.74+1.3%$0.74$0.52▼$3.33$25.11M-0.4116,239 shs269,799 shsPRPOPrecipio$17.98+4.2%$15.70$3.90▼$22.38$27.94M1.0920,239 shs23,679 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNGOBionano Genomics-1.68%-36.46%-56.00%-45.85%-92.77%DAIOData I/O+1.56%-3.26%+12.41%+12.41%+17.27%MSAIMultiSensor AI-2.39%+1.84%-2.18%+23.45%-64.22%PRPOPrecipio+5.54%-5.90%+23.53%+57.70%+163.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNGOBionano Genomics$1.68-4.5%$3.30$1.50▼$30.52$8.37M2.251.27 million shs1.04 million shsDAIOData I/O$3.25-0.3%$3.24$1.88▼$3.57$30.60M1.0435,799 shs7,812 shsMSAIMultiSensor AI$0.74+1.3%$0.74$0.52▼$3.33$25.11M-0.4116,239 shs269,799 shsPRPOPrecipio$17.98+4.2%$15.70$3.90▼$22.38$27.94M1.0920,239 shs23,679 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNGOBionano Genomics-1.68%-36.46%-56.00%-45.85%-92.77%DAIOData I/O+1.56%-3.26%+12.41%+12.41%+17.27%MSAIMultiSensor AI-2.39%+1.84%-2.18%+23.45%-64.22%PRPOPrecipio+5.54%-5.90%+23.53%+57.70%+163.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBNGOBionano Genomics 2.33Hold$7.50346.43% UpsideDAIOData I/O 3.00Buy$5.2260.62% UpsideMSAIMultiSensor AI 3.00Buy$2.50239.67% UpsidePRPOPrecipio 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BNGO, DAIO, PRPO, and MSAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025BNGOBionano GenomicsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.00 ➝ $11.007/25/2025DAIOData I/OWestpark CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.227/25/2025MSAIMultiSensor AID. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.507/8/2025DAIOData I/OWestpark CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$5.22(Data available from 9/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBNGOBionano Genomics$30.78M0.26N/AN/A$18.12 per share0.09DAIOData I/O$21.77M1.40N/AN/A$1.91 per share1.70MSAIMultiSensor AI$7.40M3.44N/AN/A$0.38 per share1.94PRPOPrecipio$18.53M1.57N/AN/A$8.16 per share2.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBNGOBionano Genomics-$112.02M-$138.92N/A∞N/A-271.02%-129.41%-72.25%11/13/2025 (Estimated)DAIOData I/O-$3.09M-$0.28N/A∞N/A-11.49%-14.60%-10.62%10/23/2025 (Estimated)MSAIMultiSensor AI-$21.50MN/A0.005.26N/A-338.72%-126.32%-97.65%11/11/2025 (Estimated)PRPOPrecipio-$4.29M-$1.19N/A∞N/A-8.48%-15.00%-10.21%11/5/2025 (Estimated)Latest BNGO, DAIO, PRPO, and MSAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025BNGOBionano Genomics-$2.69-$1.99+$0.70-$1.99$6.90 million$6.73 million8/13/2025Q2 2025MSAIMultiSensor AI-$0.10-$0.10N/A-$0.10$2.10 million$1.42 million8/13/2025Q2 2025PRPOPrecipioN/A$0.05N/A$0.05N/A$5.65 million7/24/2025Q2 2025DAIOData I/O-$0.05-$0.08-$0.03-$0.08$5.50 million$5.95 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBNGOBionano GenomicsN/AN/AN/AN/AN/ADAIOData I/ON/AN/AN/AN/AN/AMSAIMultiSensor AIN/AN/AN/AN/AN/APRPOPrecipioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBNGOBionano Genomics0.081.761.41DAIOData I/ON/A4.062.89MSAIMultiSensor AIN/A1.991.06PRPOPrecipio0.050.930.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBNGOBionano Genomics11.35%DAIOData I/O36.95%MSAIMultiSensor AI82.32%PRPOPrecipio10.45%Insider OwnershipCompanyInsider OwnershipBNGOBionano Genomics0.90%DAIOData I/O7.30%MSAIMultiSensor AI45.50%PRPOPrecipio16.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBNGOBionano Genomics3004.76 million4.71 millionOptionableDAIOData I/O1009.39 million8.70 millionOptionableMSAIMultiSensor AI3534.57 million18.84 millionN/APRPOPrecipio601.62 million1.35 millionNo DataBNGO, DAIO, PRPO, and MSAI HeadlinesRecent News About These CompaniesPrecipio Ends ATM Agreement with Alliance GlobalSeptember 4, 2025 | msn.comPrecipio Terminates Its ATMSeptember 2, 2025 | markets.businessinsider.comPrecipio, Inc. Terminates ATM Agreement with Alliance Global Partners to Strengthen Financial PositionSeptember 2, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comPrecipio Reports Improved Earnings Amidst Ongoing ChallengesAugust 16, 2025 | msn.comPrecipio, Inc. (PRPO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comPrecipio, Inc.: Precipio Announces its Q2-2025 Financial ResultsAugust 14, 2025 | finanznachrichten.dePrecipio, Inc. Reports Q2-2025 Financial Results Highlighting Revenue Growth and Improved Cash FlowAugust 13, 2025 | quiverquant.comQPrecipio Announces its Q2-2025 Financial ResultsAugust 13, 2025 | globenewswire.comPrecipio Announces Q2-2025 Shareholder Update CallJuly 31, 2025 | globenewswire.comPrecipio Enters Into Agreement With Warrant Holder To Exercise Majority ...July 13, 2025 | manilatimes.netMPrecipio amends warrant agreement, to receive $1.2M in cashJuly 13, 2025 | investing.comPrecipio, Inc. Modifies Warrant Structure to Reduce Share Dilution and Secure $1.2 Million Cash InflowJuly 11, 2025 | quiverquant.comQPrecipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As CashlessJuly 11, 2025 | globenewswire.comPrecipio, Inc. Urges Shareholders to Vote by 11 PM Today for Quorum at Upcoming MeetingJune 16, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg Buys 1,399 SharesMay 31, 2025 | insidertrades.comInsider Buying: Precipio, Inc. (NASDAQ:PRPO) Director Purchases 8,035 Shares of StockMay 23, 2025 | insidertrades.comPrecipio, Inc. (NASDAQ:PRPO) Director Purchases $36,005.97 in StockMay 22, 2025 | insidertrades.comPrecipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comPrecipio, Inc.: Precipio Announces its Q1-2025 Financial ResultsMay 15, 2025 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBNGO, DAIO, PRPO, and MSAI Company DescriptionsBionano Genomics NASDAQ:BNGO$1.68 -0.08 (-4.55%) Closing price 04:00 PM EasternExtended Trading$1.70 +0.02 (+0.89%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Data I/O NASDAQ:DAIO$3.25 -0.01 (-0.31%) Closing price 04:00 PM EasternExtended Trading$3.32 +0.06 (+2.00%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. Its programming system products are used to program integrated circuits (ICs) with the specific data for the ICs. The company offers PSV handlers off-line automated programming systems, such as PSV2800 automated programming system which focuses on high-volume manufacturing in a lower cost platform; PSV7000 automated programming system for security deployment upgrades; PSV5000 automated programming system that combines mid-range capacity and supports security deployment; and PSV3500 automated programming system which provides basic programming needs. It also provides SentriX security deployment system; and LumenX and non-automated FlashPAK III programming systems. In addition, the company offers hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, internet of things, and industrial, as well as electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.MultiSensor AI NASDAQ:MSAI$0.74 +0.01 (+1.32%) Closing price 04:00 PM EasternExtended Trading$0.75 +0.01 (+1.49%) As of 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MultiSensor AI Holdings, Inc. manufactures and distributes multi-sensor systems for thermographic and other use in various industrial applications in the United States and internationally. The company offers sensor devices ranging from small to large handheld designs with built-in displays and controls, fixed-mounted pan-tilt-zoom single- and multi-sensor camera standalone systems, and mobile multi-sensor payload and gimbal systems for unmanned aerial vehicles and unmanned ground vehicles. It also provides on-prem and cloud-based software and services, including training, calibration, and repairs for its customers operating in the distribution and logistics, manufacturing, utility, and oil and gas sectors. The company was founded in 1995 and is headquartered in Beaumont, Texas.Precipio NASDAQ:PRPO$17.98 +0.73 (+4.23%) Closing price 03:46 PM EasternExtended Trading$17.88 -0.10 (-0.56%) As of 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas These 3 Mega-Cap Giants Just Increased Dividends by 7% or More 3 High-Yields at 52-Week Lows: Buy, Sell, or Hold Advance Auto Parts is A Great Risk/Reward Play If EPS Delivers 3 Small Caps That Insiders Are Buying Amprius Technologies: Anatomy of a Textbook, Raging Bull Market Banks Boost Gold Forecasts: One Sees +30% Bull-Case Potential These 3 Stocks Boosting Buybacks Have Rallying Potential GameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
